pentylenetetrazole has been researched along with epigallocatechin gallate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delabar, JM | 1 |
| Jia, LJ; Kan, MC; Luan, SQ; Mao, ZF; Qu, ZZ; Wang, WP; Xie, T | 1 |
1 review(s) available for pentylenetetrazole and epigallocatechin gallate
| Article | Year |
|---|---|
[New perspectives on molecular and genic therapies in Down syndrome].
Topics: Animals; Catechin; Chromosomes, Human, Pair 21; Disease Models, Animal; Down Syndrome; Droxidopa; Drug Delivery Systems; Fluoxetine; Forecasting; Gene Expression Regulation; Genetic Association Studies; Genetic Therapy; Hedgehog Proteins; Humans; Memantine; Mice; Mice, Transgenic; Models, Genetic; Neuronal Plasticity; Neurotransmitter Agents; Pentylenetetrazole; Phenotype; Signal Transduction | 2010 |
1 other study(ies) available for pentylenetetrazole and epigallocatechin gallate
| Article | Year |
|---|---|
Effects of epigallocatechin-3-gallate on pentylenetetrazole-induced kindling, cognitive impairment and oxidative stress in rats.
Topics: Animals; Brain; Catechin; Cognition; Convulsants; Kindling, Neurologic; Male; Maze Learning; Neuroprotective Agents; Oxidative Stress; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Seizures | 2012 |